- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Nano-drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Nano-drug market. Detailed analysis of key players, along with key growth strategies adopted by Nano-drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis
Stryker
Navidea Biopharmaceuticals
Samyang Biopharm
Pfizer
Par Pharmaceutical
Selecta Biosciences
Kaken Pharmaceutical
Mitsubishi Pharma
Cerulean Pharma
GlaxoSmithKline
Gilead Sciences
Johnson & Johnson
Celgene
Roche
Astrazeneca
Abbott
Kadmon Pharmaceuticals
OSI Pharmaceuticals
Merck
Eli Lilly
Lummy
Novavax
Sanofi
By Type:
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
By End-User:
Cancer and Tumors
Autoimmune Disorders
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Nano-drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Nano-drug Market Size and Growth Rate of Liposomes from 2016 to 2027
-
1.3.2 USA Nano-drug Market Size and Growth Rate of Polymeric Micelles from 2016 to 2027
-
1.3.3 USA Nano-drug Market Size and Growth Rate of Solid lipid Nanoparticles from 2016 to 2027
-
1.3.4 USA Nano-drug Market Size and Growth Rate of Microemulsion and Nanoemulsion from 2016 to 2027
-
1.3.5 USA Nano-drug Market Size and Growth Rate of Nanosuspension from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Nano-drug Market Size and Growth Rate of Cancer and Tumors from 2016 to 2027
-
1.4.2 USA Nano-drug Market Size and Growth Rate of Autoimmune Disorders from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Nano-drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Nano-drug by Major Types
-
3.4.1 Market Size and Growth Rate of Liposomes
-
3.4.2 Market Size and Growth Rate of Polymeric Micelles
-
3.4.3 Market Size and Growth Rate of Solid lipid Nanoparticles
-
3.4.4 Market Size and Growth Rate of Microemulsion and Nanoemulsion
-
3.4.5 Market Size and Growth Rate of Nanosuspension
4 Segmentation of Nano-drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Nano-drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Nano-drug in Cancer and Tumors
-
4.4.2 Market Size and Growth Rate of Nano-drug in Autoimmune Disorders
5 Market Analysis by Regions
-
5.1 USA Nano-drug Production Analysis by Regions
-
5.2 USA Nano-drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Nano-drug Landscape Analysis
-
6.1 West USA Nano-drug Landscape Analysis by Major Types
-
6.2 West USA Nano-drug Landscape Analysis by Major End-Users
7 South USA Nano-drug Landscape Analysis
-
7.1 South USA Nano-drug Landscape Analysis by Major Types
-
7.2 South USA Nano-drug Landscape Analysis by Major End-Users
8 Middle West USA Nano-drug Landscape Analysis
-
8.1 Middle West USA Nano-drug Landscape Analysis by Major Types
-
8.2 Middle West USA Nano-drug Landscape Analysis by Major End-Users
9 Northeast USA Nano-drug Landscape Analysis
-
9.1 Northeast USA Nano-drug Landscape Analysis by Major Types
-
9.2 Northeast USA Nano-drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novartis
-
10.1.1 Novartis Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Stryker
-
10.2.1 Stryker Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Navidea Biopharmaceuticals
-
10.3.1 Navidea Biopharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Samyang Biopharm
-
10.4.1 Samyang Biopharm Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Pfizer
-
10.5.1 Pfizer Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Par Pharmaceutical
-
10.6.1 Par Pharmaceutical Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Selecta Biosciences
-
10.7.1 Selecta Biosciences Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Kaken Pharmaceutical
-
10.8.1 Kaken Pharmaceutical Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Mitsubishi Pharma
-
10.9.1 Mitsubishi Pharma Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Cerulean Pharma
-
10.10.1 Cerulean Pharma Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 GlaxoSmithKline
-
10.11.1 GlaxoSmithKline Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Gilead Sciences
-
10.12.1 Gilead Sciences Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Johnson & Johnson
-
10.13.1 Johnson & Johnson Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Celgene
-
10.14.1 Celgene Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Roche
-
10.15.1 Roche Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Astrazeneca
-
10.16.1 Astrazeneca Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 Abbott
-
10.17.1 Abbott Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
-
10.18 Kadmon Pharmaceuticals
-
10.18.1 Kadmon Pharmaceuticals Company Profile and Recent Development
-
10.18.2 Market Performance
-
10.18.3 Product and Service Introduction
-
10.19 OSI Pharmaceuticals
-
10.19.1 OSI Pharmaceuticals Company Profile and Recent Development
-
10.19.2 Market Performance
-
10.19.3 Product and Service Introduction
-
10.20 Merck
-
10.20.1 Merck Company Profile and Recent Development
-
10.20.2 Market Performance
-
10.20.3 Product and Service Introduction
-
10.21 Eli Lilly
-
10.21.1 Eli Lilly Company Profile and Recent Development
-
10.21.2 Market Performance
-
10.21.3 Product and Service Introduction
-
10.22 Lummy
-
10.22.1 Lummy Company Profile and Recent Development
-
10.22.2 Market Performance
-
10.22.3 Product and Service Introduction
-
10.23 Novavax
-
10.23.1 Novavax Company Profile and Recent Development
-
10.23.2 Market Performance
-
10.23.3 Product and Service Introduction
-
10.24 Sanofi
-
10.24.1 Sanofi Company Profile and Recent Development
-
10.24.2 Market Performance
-
10.24.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Nano-drug Market Size and Growth Rate of Liposomes from 2016 to 2027
-
Figure USA Nano-drug Market Size and Growth Rate of Polymeric Micelles from 2016 to 2027
-
Figure USA Nano-drug Market Size and Growth Rate of Solid lipid Nanoparticles from 2016 to 2027
-
Figure USA Nano-drug Market Size and Growth Rate of Microemulsion and Nanoemulsion from 2016 to 2027
-
Figure USA Nano-drug Market Size and Growth Rate of Nanosuspension from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Nano-drug Market Size and Growth Rate of Cancer and Tumors from 2016 to 2027
-
Figure USA Nano-drug Market Size and Growth Rate of Autoimmune Disorders from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Nano-drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Nano-drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Nano-drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Nano-drug by Different Types from 2016 to 2027
-
Table Consumption Share of Nano-drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Liposomes
-
Figure Market Size and Growth Rate of Polymeric Micelles
-
Figure Market Size and Growth Rate of Solid lipid Nanoparticles
-
Figure Market Size and Growth Rate of Microemulsion and Nanoemulsion
-
Figure Market Size and Growth Rate of Nanosuspension
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Nano-drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Nano-drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cancer and Tumors
-
Figure Market Size and Growth Rate of Autoimmune Disorders
-
Table USA Nano-drug Production by Regions
-
Table USA Nano-drug Production Share by Regions
-
Figure USA Nano-drug Production Share by Regions in 2016
-
Figure USA Nano-drug Production Share by Regions in 2021
-
Figure USA Nano-drug Production Share by Regions in 2027
-
Table USA Nano-drug Consumption by Regions
-
Table USA Nano-drug Consumption Share by Regions
-
Figure USA Nano-drug Consumption Share by Regions in 2016
-
Figure USA Nano-drug Consumption Share by Regions in 2021
-
Figure USA Nano-drug Consumption Share by Regions in 2027
-
Table West USA Nano-drug Consumption by Types from 2016 to 2027
-
Table West USA Nano-drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Nano-drug Consumption Share by Types in 2016
-
Figure West USA Nano-drug Consumption Share by Types in 2021
-
Figure West USA Nano-drug Consumption Share by Types in 2027
-
Table West USA Nano-drug Consumption by End-Users from 2016 to 2027
-
Table West USA Nano-drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Nano-drug Consumption Share by End-Users in 2016
-
Figure West USA Nano-drug Consumption Share by End-Users in 2021
-
Figure West USA Nano-drug Consumption Share by End-Users in 2027
-
Table South USA Nano-drug Consumption by Types from 2016 to 2027
-
Table South USA Nano-drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Nano-drug Consumption Share by Types in 2016
-
Figure South USA Nano-drug Consumption Share by Types in 2021
-
Figure South USA Nano-drug Consumption Share by Types in 2027
-
Table South USA Nano-drug Consumption by End-Users from 2016 to 2027
-
Table South USA Nano-drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Nano-drug Consumption Share by End-Users in 2016
-
Figure South USA Nano-drug Consumption Share by End-Users in 2021
-
Figure South USA Nano-drug Consumption Share by End-Users in 2027
-
Table Middle West USA Nano-drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Nano-drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Nano-drug Consumption Share by Types in 2016
-
Figure Middle West USA Nano-drug Consumption Share by Types in 2021
-
Figure Middle West USA Nano-drug Consumption Share by Types in 2027
-
Table Middle West USA Nano-drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Nano-drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Nano-drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Nano-drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Nano-drug Consumption Share by End-Users in 2027
-
Table Northeast USA Nano-drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Nano-drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Nano-drug Consumption Share by Types in 2016
-
Figure Northeast USA Nano-drug Consumption Share by Types in 2021
-
Figure Northeast USA Nano-drug Consumption Share by Types in 2027
-
Table Northeast USA Nano-drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Nano-drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Nano-drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Nano-drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Nano-drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Stryker
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stryker
-
Figure Sales and Growth Rate Analysis of Stryker
-
Figure Revenue and Market Share Analysis of Stryker
-
Table Product and Service Introduction of Stryker
-
Table Company Profile and Development Status of Navidea Biopharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea Biopharmaceuticals
-
Figure Sales and Growth Rate Analysis of Navidea Biopharmaceuticals
-
Figure Revenue and Market Share Analysis of Navidea Biopharmaceuticals
-
Table Product and Service Introduction of Navidea Biopharmaceuticals
-
Table Company Profile and Development Status of Samyang Biopharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samyang Biopharm
-
Figure Sales and Growth Rate Analysis of Samyang Biopharm
-
Figure Revenue and Market Share Analysis of Samyang Biopharm
-
Table Product and Service Introduction of Samyang Biopharm
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Par Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Par Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Par Pharmaceutical
-
Figure Revenue and Market Share Analysis of Par Pharmaceutical
-
Table Product and Service Introduction of Par Pharmaceutical
-
Table Company Profile and Development Status of Selecta Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Selecta Biosciences
-
Figure Sales and Growth Rate Analysis of Selecta Biosciences
-
Figure Revenue and Market Share Analysis of Selecta Biosciences
-
Table Product and Service Introduction of Selecta Biosciences
-
Table Company Profile and Development Status of Kaken Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kaken Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Kaken Pharmaceutical
-
Figure Revenue and Market Share Analysis of Kaken Pharmaceutical
-
Table Product and Service Introduction of Kaken Pharmaceutical
-
Table Company Profile and Development Status of Mitsubishi Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Pharma
-
Figure Sales and Growth Rate Analysis of Mitsubishi Pharma
-
Figure Revenue and Market Share Analysis of Mitsubishi Pharma
-
Table Product and Service Introduction of Mitsubishi Pharma
-
Table Company Profile and Development Status of Cerulean Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cerulean Pharma
-
Figure Sales and Growth Rate Analysis of Cerulean Pharma
-
Figure Revenue and Market Share Analysis of Cerulean Pharma
-
Table Product and Service Introduction of Cerulean Pharma
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Gilead Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
-
Figure Sales and Growth Rate Analysis of Gilead Sciences
-
Figure Revenue and Market Share Analysis of Gilead Sciences
-
Table Product and Service Introduction of Gilead Sciences
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Astrazeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca
-
Figure Sales and Growth Rate Analysis of Astrazeneca
-
Figure Revenue and Market Share Analysis of Astrazeneca
-
Table Product and Service Introduction of Astrazeneca
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Kadmon Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kadmon Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Kadmon Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Kadmon Pharmaceuticals
-
Table Product and Service Introduction of Kadmon Pharmaceuticals
-
Table Company Profile and Development Status of OSI Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals
-
Figure Revenue and Market Share Analysis of OSI Pharmaceuticals
-
Table Product and Service Introduction of OSI Pharmaceuticals
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Lummy
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lummy
-
Figure Sales and Growth Rate Analysis of Lummy
-
Figure Revenue and Market Share Analysis of Lummy
-
Table Product and Service Introduction of Lummy
-
Table Company Profile and Development Status of Novavax
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax
-
Figure Sales and Growth Rate Analysis of Novavax
-
Figure Revenue and Market Share Analysis of Novavax
-
Table Product and Service Introduction of Novavax
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-

Chinese